Abstract
Purpose
This randomized crossover trial investigated the effects of Daikenchuto (DKT: TJ-100) on gastrointestinal symptoms of patients after colon and rectosigmoid cancer surgery.
Methods
Among patients who had completed surgery for colon cancer, including rectosigmoid cancer, over 6 months ago, 20 who complained of gastrointestinal symptoms were enrolled. Subjects were randomly assigned to two sequences: sequences: A and B. In period 1, sequence A subjects were orally administered DKT, whereas sequence B subjects were untreated for 28 days. After a 5-day interval, in period 2, sequences A and B were reversed. Quality-of-life markers (GSRS and VAS), the Sitzmark transit study, the orocecal transit time (lactulose hydrogen breath test) and Gas volume score were evaluated before and after each period with findings compared between the presence of absence of DKT administration.
Results
Between sequences, there were no significant differences in clinicopathological characters or any evaluations before randomization. There was no carryover effect in this crossover trial. The administration of DKT significantly ameliorated the GSRS in total, indigestion, and diarrhea, although the planned number of subjects for inclusion in this trial was not reached.
Conclusions
DKT may ameliorate subjective symptoms for postoperative patients who complain of gastrointestinal symptoms.
Similar content being viewed by others
Data availability
The datasets analyzed during the current study are available from the corresponding author on reasonable request.
References
Downing A, Morris EJA, Richards M, Corner J, Wright P, Sebag-Montefiore D, et al. Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12–36 months after diagnosis. J Clin Oncol. 2015;33:616–24.
Brigic A, Sakuma S, Lovegrove RE, Bassett P, Faiz O, Clark SK, et al. A prospective case control study of functional outcomes and related quality of life after colectomy for neoplasia. Int J Colorectal Dis. 2017;32:777–87.
Hope C, Reilly J, Lund J, Andreyev H. Systematic review: the effect of right hemicolectomy for cancer on postoperative bowel function. Support Care Cancer. 2020;28:4549–59.
Rana SV, Malik A. Hydrogen breath tests in gastrointestinal diseases. Indian J Clin Biochem. 2014;29:398–405.
Horiuchi A. Effect of traditional Japanese medicine, Daikenchuto (TJ-100) in patients with chronic constipation. Gastroenterol Res. 2010;3:151–5.
Wakasugi M, Suzuki Y, Tei M, Ueshima S, Akamatsu H, Nishida T. Effects of Daikenchuto on postoperative gastrointestinal motility in colorectal carcinoma patients with abdominal pain and distension: a prospective, randomized trial. Surg Today. 2020;50:1524–9.
Fujita F, Torashima Y, Inoue Y, Ito S, Kobayashi K, Kanetaka K, et al. Daikenchuto improved perioperative nutritional status of the patients with colorectal cancer: a prospective open-labeled randomized exploratory study. Interv Med Appl Sci. 2019;11:84–8.
Kono T, Shimada M, Nishi M, Morine Y, Yoshikawa K, Katsuno H, et al. Daikenchuto accelerates the recovery from prolonged postoperative ileus after open abdominal surgery: a subgroup analysis of three randomized controlled trials. Surg Today. 2019;49:704–11.
Aoyama T, Tamagawa H. The clinical effect of Kampo medicine in multimodal treatment for gastrointestinal cancer in Japan. J Cancer. 2020;11:5390–4.
Munekage M, Kitagawa H, Ichikawa K, Watanabe J, Aoki K, Kono T, et al. Pharmacokinetics of Daikenchuto, a traditional Japanese medicine (Kampo) after single oral administration to healthy Japanese volunteers. Drug Metab Dispos. 2011;39:1784–8.
Svedlund J, Sjödin I, Dotevall G. GSRS-A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129–34.
Miyoshi K, Fuchimoto S, Ohsaki T, Sakata T, Ohtsuka S, Takakura N. Long-term effects of jejunal pouch added to Roux-en-Y reconstruction after total gastrectomy. Gastric Cancer. 2001;4:156–61.
Hinton JM, Lennard-Jones E, Young C. A new method for studying gut transit times using radioopaque markers. Gut. 1969;10(10):842–7.
Yamada T, Matsumoto S, Matsuda MKA, Shinji S, Yokoyama Y, Takahashi G, et al. The effect of Daikenchuto on postoperative intestinal motility in patients with right-side colon cancer. Surg Today. 2017;47:865–71.
Rana SV, Malik A. Breath tests and irritable bowel syndrome. World J Gastroenterol. 2014;28:7587–601.
Koide A, Yamaguchi T, Odaka T, Koyama H, Tsuyuguchi T, Kitahara H, et al. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol. 2000;95:1735–41.
Rasband WS. ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, imagej.nih.gov/ij/1997–2012.
Numata T, Takayama S, Tobita M, Ishida S, Katayose D, Shinkawa M, et al. Traditional Japanese medicine Daikenchuto improves functional constipation in poststroke patients. Evid-Based Complement Altern Med. 2014. https://doi.org/10.1155/2014/231258.
Wellek S, Blettner M. On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2012;109(15):276–81.
Bond JH, Levitt MD. Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med. 1975;85:546–55.
Scarpello JH, Greaves M, Sladen GE. Small intestinal transit in diabetics. Br Med J. 1976;20:1225–6.
Park SY, Park HB, Lee JM, Lee HJ, Park CH, Kim HS, et al. Relevance of colonic gas analysis and transit study in patients with chronic constipation. J Neurogastroenterol Motil. 2015;21:433–9.
Sasaki K, Sasaki D, Sasaki K, Nishidono Y, Yamamori A, Tanaka K, et al. Growth stimulation of Bifidobacterium from human colon using Daikenchuto in an in vitro model of human intestinal microbiota. Sci Rep. 2021;11:4580. https://doi.org/10.1038/s41598-021-84167-z.
Hasebe T, Ueno N, Musch MW, Nadimpalli A, Kaneko A, Kaifuchi N, et al. Daikenchuto (TU-100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K. Pharmacol Res Perspect. 2016;4: e00215.
Takayama S, Seki T, Watanabe M, Monma Y, Sugita N, Konno S, et al. The herbal medicine Daikenchuto increases blood flow in the superior mesenteric artery. Tohoku J Exp Med. 2009;12:319–30.
Suzuki K, Takehara Y, Sakata M, Kawate M, Ohishi N, Sugiyama K, et al. Daikenchuto increases blood flow in the superior mesenteric artery in humans: A comparison study between four-dimensional phase-contrast vastly undersampled isotropic projection reconstruction magnetic resonance imaging and Doppler ultrasound. PLoS ONE. 2021;16: e0245878. https://doi.org/10.1371/journal.pone.0245878.
Hayakawa T, Kase Y, Saito K, Hashimoto K, Ishige A, Komatsu Y, et al. Effects of Dai-kenchu-to on intestinal obstruction following laparotomy. J Smooth Muscle Res. 1999;35:47–54.
Kubota K, Mase A, Matsushima H, Fujitsuka N, Yamamoto M, Morine Y, et al. Daikenchuto, a traditional Japanese herbal medicine, promotes colonic transit by inducing a propulsive movement pattern. Neurogastroenterol Motil. 2019;31: e13689.
Hiraishi K, Kurahara LH, Sumiyoshi M, Hu YP, Koga K, Onitsuka M, et al. Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel. World J Gastroenterol. 2018;24:4036–53.
Kono T, Kaneko A, Omiya Y, Ohbuchi K, Ohno N, Yamamoto M. Epithelial transient receptor potential ankyrin 1 (TRPA1)-dependent adrenomedullin upregulates blood flow in rat small intestine. Am J Physiol - Gastrointest Liver Physiol. 2013;304:G428–36.
Kono T, Kaneko A, Hira Y, Suzuki T, Chisato N, Ohtake N, et al. Anti-colitis and -adhesion effects of Daikenchuto via endogenous adrenomedullin enhancement in Crohn’s disease mouse model. J Crohn’s Colitis. 2010;4:161–70.
Hoshino N, Kawada K, Hida K, Wada T, Takahashi R, Yoshitomi M, et al. Effect of Daikenchuto (TJ-100) on gastrointestinal symptoms following laparoscopic colectomy in patients with colon cancer: study protocol for a randomized controlled trial. Trials. 2017;18:553.
Acknowledgements
The authors have no acknowledgments to report.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sada, H., Sawada, H., Tokunaga, M. et al. Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal symptoms in patients with a history of colon and rectosigmoid cancer surgery: a randomized crossover study. Surg Today 53, 873–881 (2023). https://doi.org/10.1007/s00595-022-02640-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-022-02640-2